Canadians kept in dark about defective drugs
U.S. inspections of Canadian drug companies reveal systemic problems that have put Canadian patients at risk.
By: David Bruser News Reporter, Jesse McLean Investigative News reporter, Published on Thu Sep 11 2014
North American patients have been put at risk by prescription drugs that Canadian pharmaceutical companies sold with knowledge that their products were defective, a Star investigation has found.
Using records obtained through U.S. freedom of information laws, the Star also found other Canadian companies have:
Hidden, altered and in some cases destroyed test data that showed their products were tainted or potentially unsafe.
Not reported evidence of side-effects suffered by consumers taking their drugs...
